Minerva Surgical (Minerva Surgical) Gross Margin % : 51.97% (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Minerva Surgical Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Minerva Surgical's Gross Profit for the three months ended in Sep. 2023 was $6.22 Mil. Minerva Surgical's Revenue for the three months ended in Sep. 2023 was $11.97 Mil. Therefore, Minerva Surgical's Gross Margin % for the quarter that ended in Sep. 2023 was 51.97%.

The historical rank and industry rank for Minerva Surgical's Gross Margin % or its related term are showing as below:

UTRS' s Gross Margin % Range Over the Past 10 Years
Min: 45.38 Med: 52.4 Max: 58.58
Current: 54.18

During the past 4 years, the highest Gross Margin % of Minerva Surgical was 58.58%. The lowest was 45.38%. And the median was 52.40%.

UTRS's Gross Margin % is ranked better than
51.13% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.295 vs UTRS: 54.18

Minerva Surgical had a gross margin of 51.97% for the quarter that ended in Sep. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Minerva Surgical was 0.00% per year.

Minerva Surgical Gross Margin % Historical Data

The historical data trend for Minerva Surgical's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minerva Surgical Gross Margin % Chart

Minerva Surgical Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Gross Margin %

45.38

50.62

58.58

54.17

Minerva Surgical Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Gross Margin %	Get a 7-Day Free Trial										54.12	53.40	55.97	55.28	51.97

Competitive Comparison of Minerva Surgical's Gross Margin %

For the Medical Devices subindustry, Minerva Surgical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Minerva Surgical's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Minerva Surgical's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Minerva Surgical's Gross Margin % falls into.

Minerva Surgical Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Minerva Surgical's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )	=	Gross Profit (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	27.2	/	50.294
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(50.294 - 23.052)	/	50.294
	=	54.17 %

Minerva Surgical's Gross Margin for the quarter that ended in Sep. 2023 is calculated as

Gross Margin % (Q: Sep. 2023 )	=	Gross Profit (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	6.2	/	11.965
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(11.965 - 5.747)	/	11.965
	=	51.97 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Minerva Surgical (OTCPK:UTRS) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Minerva Surgical had a gross margin of 51.97% for the quarter that ended in Sep. 2023 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Minerva Surgical Gross Margin % Related Terms

Thank you for viewing the detailed overview of Minerva Surgical's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Minerva Surgical (Minerva Surgical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Minerva Surgical Inc (OTCPK:UTRS) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

4255 Burton Drive, Santa Clara, CA, USA, 95054

Website

https://www.minervasurgical.com

Minerva Surgical Inc is a medical device company that develops therapeutic devices that treat abnormal uterine bleeding in a minimally invasive manner. The Company operates and manages its business as one reportable and operating segment, which is the business of research, development, and sale of therapeutic devices for abnormal uterine bleeding treatment.

Executives

Daniel Cohen	director	C/O ACCELMED, 848 BRICKELL AVE, #901, MIAMI FL 33131
Accelmed Partners Ii L.p.	10 percent owner	2875 NE 191ST, SUITE 500, AVENTURA FL 33180
New Enterprise Associates 13 Lp	10 percent owner	1119 ST PAUL STREET, BALTIMORE MD 21202
Uri Geiger	director, 10 percent owner	221 LATHROP WAY, SUITE I, SACRAMENTO CA 95815
Todd Usen	director, officer: Chief Executive Officer	C/O MINERVA SURGICAL, INC., 4255 BURTON DRIVE, SANTA CLARA CA 95054
Derrick Sung	director	C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 380, SAN FRANCISCO CA 94103
David M Clapper	director, officer: President and CEO	3003 TASMAN DRIVE, SANTA CLARA CA 95054
Novo Holdings A/s	10 percent owner	TUBORG HAVNEVEJ 19, HELLERUP G7 2900
Jaffe Ross A Md	director	ONE SANSOME STREET, SUITE 3630, SAN FRANCISCO CA 94104
Evgueni V. Skalnyi	officer: VP Medical Affairs	C/O MINERVA SURGICAL, INC., 4225 BURTON DRIVE, SANTA CLARA CA 95054
Dominique J. Filloux	officer: COO	C/O MINERVA SURGICAL, INC., 4225 BURTON DRIVE, SANTA CLARA CA 95054
Joel R Jung	officer: CFO	1401 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Niquette L. Hunt	director	SOLITON, INC., 5304 ASHBROOK DRIVE, HOUSTON TX 77081
Jill Anderson	director	1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Nea Partners 13, Limited Partnership	10 percent owner	1119 ST. PAUL STREET, BALTIMORE MD 21202